First patients test promising new weapon against tough cancers
NCT ID NCT05156866
Summary
This is the first time a new drug called TORL-2-307-ADC is being tested in people. The main goal is to find a safe dose and see how the body handles it in 163 patients with advanced solid tumors, including stomach and pancreatic cancer. Researchers will also look for early signs that the drug might help shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, 46804, United States
-
Providence St. Jude Medical Center
Fullerton, California, 92835, United States
-
START San Antonio
San Antonio, Texas, 78229, United States
-
Seoul National University Bundang Hospital
Seoul, 13620, South Korea
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, 03722, South Korea
-
Texas Oncology-Austin
Austin, Texas, 78705, United States
-
Texas Oncology-Dallas
Dallas, Texas, 75246, United States
-
Texas Oncology-Tyler
Tyler, Texas, 75702, United States
-
Torrance Memorial Medical
Torrance, California, 90505, United States
-
UCLA - JCCC Clinical Research Unit
Los Angeles, California, 90095, United States
-
Washington University School of Medicine-Siteman Cancer Center
St Louis, Missouri, 63310, United States
Conditions
Explore the condition pages connected to this study.